Abstract
Background
Medication Therapy Management (MTM) is a patient-centered service that optimizes drug therapy, improves clinical outcomes, and enhances quality of life. Pharmacists play a critical role in MTM services and provide comprehensive medication management for patients with attention deficit hyperactivity disorder (ADHD).
Aim
The aim of this study was to assess the knowledge, attitude, and readiness of Iraqi community pharmacists regarding MTM services for ADHD patients.
Method
A cross-sectional study was conducted among 480 Iraqi pharmacists working in community pharmacies in Baghdad. Data were collected using a pre-validated, self-administered questionnaire with 34 items.
Results
Results showed that only 127 (26.5%) pharmacists had good knowledge, 146 (30.4%) had good attitude, and 148 (30.8%) had high readiness regarding MTM services in ADHD patients. Multivariate analyses showed that a higher number of hours worked per week in the hospital was significantly associated with a lower likelihood of high attitude, whereas practicing MTM services, high knowledge, and high attitude were significantly associated with a higher likelihood of high readiness.
Conclusion
The findings of this study indicate that knowledge, attitudes, and readiness for MTM services for ADHD patients are inadequate. Therefore, there is an urgent need for effective educational strategies to better prepare pharmacists for their potential role in the community, particularly for providing MTM services to ADHD patients.
Similar content being viewed by others
References
Cabral MDI, Liu S, Soares N. Attention-deficit/hyperactivity disorder: diagnostic criteria, epidemiology, risk factors and evaluation in youth. Transl Pediatr. 2020;9:S104–13.
Yuen T, Zhang H, Bonin RP. Pharmacists’ knowledge, experiences and perceptions of treatments for attention-deficit/hyperactivity disorder. Can Pharm J Rev Pharm Can. 2021;154:110–9.
Caye A, Swanson JM, Coghill D, et al. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2019;24:390–408.
xxxx
Stuhec M, Lukić P, Locatelli I. Efficacy, acceptability, and tolerability of lisdexamfetamine, mixed amphetamine salts, methylphenidate, and modafinil in the treatment of attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis. Ann Pharmacother. 2019;53:121–33.
Toomey SL, Sox CM, Rusinak D, et al. Why do children with ADHD discontinue their medication? Clin Pediatr (Phila). 2012;51:763–9.
Marupuru S, Roether A, Guimond AJ, et al. A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. Healthcare. 2022;10:1207.
Ferreri SP, Hughes TD, Snyder ME. Medication therapy management: current challenges. Integr Pharm Res Pract. 2020;9:71–81.
Hohmeier KC, Wheeler JS, Turner K, et al. Targeting adaptability to improve medication therapy management (MTM) implementation in community pharmacy. Implement Sci. 2019;14:99.
Pellegrino AN, Martin MT, Tilton JJ, et al. Medication therapy management services: definitions and outcomes. Drugs. 2009;69:393–406.
Stuhec M, Locatelli I. Age-related pharmacotherapy of attention deficit hyperactivity disorder in Slovenia in children and adolescents: Aa population-based study. Eur Psychiatry. 2017;42:129–33.
Štuhec M, Švab V. Atomoxetine-induced life-threatening long QT syndrome. Ir J Med Sci. 2013;182:535–7.
Smith M, Bates DW, Bodenheimer T, et al. Why pharmacists belong in the medical home. Health Aff (Millwood). 2010;29:906–13.
Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.
Kogut S, Goldstein E, Charbonneau C, et al. Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study. Drug Healthc Patient Saf. 2014;6:1–6.
Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23–31.
Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16:185–95.
Lee KC, Kim E, Kim J, et al. Development of an innovative adult attention-deficit hyperactivity disorder clinic. Ment Health Clin. 2020;10:296–300.
Pindolia VK, Stebelsky L, Romain TM, et al. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother. 2009;43:611–20.
Oladapo AO, Rascati KL. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J Pharm Pract. 2012;25:457–70.
Al-Tameemi NK, Sarriff A. Knowledge, attitude and practice of pharmacists on medication therapy management: a survey in Hospital Pulau Pinang, Penang. Malaysia J Pharm Health Care Sci. 2019;5:1.
Domiati S, Sacre H, Lahoud N, et al. Knowledge of and readiness for medication therapy management among community pharmacists in Lebanon. Int J Clin Pharm. 2018;40:1165–74.
Jarab AS, Al-Qerem W, Mukattash TL, et al. Pharmacists’ knowledge and attitudes toward medication therapy management service and the associated challenges and barriers for its implementation. Saudi Pharm J. 2022;30:842–8.
German A, Johnson L, Ybarra G, et al. Assessment of pharmacists’ self-reported preparedness to provide pharmacotherapy services to individuals with psychiatric disorders. Ment Health Clin. 2018;8:1–6.
Khan N, McGarry K, Naqvi AA, et al. Pharmacists’ viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan. BMC Health Serv Res. 2020;20:610.
Acknowledgements
The authors gratefully acknowledge the contribution of pharmacy students of the Scientific Society of the College of Pharmacy at the American University of Iraq—Baghdad (AUIB) for their valuable help in visiting 480 community pharmacies in Baghdad, the capital of Iraq, to collect the data. The authors would also like to thank all the participating pharmacists who spent their valuable time completing the questionnaire.
Funding
No specific funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Al-Dujaili, Z., Hallit, S. & Al Faraj, A. Knowledge, attitude, and readiness of pharmacists toward medication therapy management for patients with attention deficit hyperactivity disorder: a cross-sectional quantitative study. Int J Clin Pharm 45, 1277–1285 (2023). https://doi.org/10.1007/s11096-023-01628-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-023-01628-3